Glenmede Trust’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-375
| Closed | – | – | 3000 |
|
|
2019
Q3 | $0 | Hold |
375
| – | – | ﹤0.01% | 2999 |
|
|
2019
Q2 | $1 | Hold |
375
| – | – | ﹤0.01% | 2934 |
|
|
2019
Q1 | $1 | Buy |
+375
| New | +$1 | ﹤0.01% | 2905 |
|
|
2018
Q4 | – | Sell |
-8,823
| Closed | -$119K | – | 3007 |
|
|
2018
Q3 | $119K | Hold |
8,823
| – | – | ﹤0.01% | 1270 |
|
|
2018
Q2 | $105K | Hold |
8,823
| – | – | ﹤0.01% | 1247 |
|
|
2018
Q1 | $58K | Hold |
8,823
| – | – | ﹤0.01% | 1571 |
|
|
2017
Q4 | $58K | Hold |
8,823
| – | – | ﹤0.01% | 1571 |
|
|
2017
Q3 | $72K | Hold |
8,823
| – | – | ﹤0.01% | 1510 |
|
|
2017
Q2 | $48K | Hold |
8,823
| – | – | ﹤0.01% | 1610 |
|
|
2017
Q1 | $48K | Hold |
8,823
| – | – | ﹤0.01% | 1610 |
|
|
2016
Q4 | $35K | Sell |
8,823
-1,175
| -12% | -$4.66K | ﹤0.01% | 1713 |
|
|
2016
Q3 | $70K | Sell |
9,998
-10,925
| -52% | -$76.5K | ﹤0.01% | 1489 |
|
|
2016
Q2 | $170K | Buy |
20,923
+17,823
| +575% | +$145K | ﹤0.01% | 1219 |
|
|
2016
Q1 | $25K | Hold |
3,100
| – | – | ﹤0.01% | 1739 |
|
|
2015
Q4 | $37K | Buy |
3,100
+600
| +24% | +$7.16K | ﹤0.01% | 1659 |
|
|
2015
Q3 | $29K | Buy |
2,500
+675
| +37% | +$7.83K | ﹤0.01% | 1770 |
|
|
2015
Q2 | $33K | Buy |
+1,825
| New | +$33K | ﹤0.01% | 1753 |
|